Current therapeutic options and novel molecular markers in skull base chordomas

Neurosurgical Review

Volumn 35, Issue 1, 2012, Pages 1-14

  Gagliardi, Filippo ^a   Boari, Nicola ^a   Riva, Paola ^b   Mortini, Pietro ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemotherapy; Molecular markers; Radiation therapy; Skull base chordomas; Skull base surgery

Indexed keywords

2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADRENALIN; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETOPOSIDE; IFOSFAMIDE; IMATINIB; TUMOR MARKER;

AGE DISTRIBUTION; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHORDOMA; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DIPLOPIA; DISEASE MARKER; DRUG POTENTIATION; DRUG TARGETING; FUNCTIONAL STATUS; HEADACHE; HISTOPATHOLOGY; HUMAN; LIQUORRHEA; MENINGITIS; MOLECULAR BIOLOGY; MULTIMODALITY CANCER THERAPY; NONHUMAN; OVERALL SURVIVAL; PATIENT SAFETY; PHOTON THERAPY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SEX RATIO; SKULL BASE CHORDOMA; SKULL BASE TUMOR; SURGICAL MORTALITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; FEMALE; MALE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; CHORDOMA; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SKULL BASE NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84862630138     PISSN: 03445607     EISSN: 14372320     Source Type: Journal    
DOI: 10.1007/s10143-011-0354-1     Document Type: Review

References (92)

1. Al-Mefty O, Borba LA (1997) Skull base chordomas: a management challenge. J Neurosurg 86(2):182-189
2. Amendola BE, Amendola MA, Oliver E et al (1986) Chordoma: role of radiation therapy. Radiology 158:839-843
3. Arnautovic KI, Al-Mefty O (2001) Surgical seeding of chordomas. J Neurosurg 95:798-803
4. Austin JP, Urie MM, Cardenosa G et al (1993) Probabile causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 25:439-444
5. Austin-Seymour M, Munzenrider J, Goitein M et al (1989) Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70:13-17
6. Benk V, Liebsch NJ, Munzenrider JE et al (1995) Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 31:577-581
7. Berson AM, Castro JR, Petti P et al (1988) Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 15:559-565
8. Borba LA, Al-Mefty O, Mrak RE et al (1996) Cranial chordomas in children and adolescents. J Neurosurg 84:584-591
9. Brooks JJ, LiVolsi VA, Trojanowski J (1987) Does chondroid chordoma exist? Acta Neuropathol (Berl) 72:229-235
10. Camacho-Arroyo I, González-Agüero G, Gamboa-Domínguez A et al (2000) Progesterone receptor isoforms expression pattern in human chordomas. J Neurooncol 49(1):1-7
11. Carpentier A, Polivka M, Blanquet A et al (2002) Suboccipital and cervical chordomas: the value of aggressive treatment at first presentation of the disease. J Neurosurg 97(5):1070-7
12. Casali PG, Messina A, Stacchiotti S et al (2004) Imatinib mesylate in chordoma. Cancer 101(9):2086-2097
13. Castro JR, Linstadt DE, Bahary JP et al (1994) Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 29:647-655
14. Chetiyawardana AD (1984) Chordoma: results of treatment. Clin Radiol 35:159-161
15. Chetty R, Levin CV, Kalan MR (1991) Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. J Surg Oncol 46:261-264
16. Cho YH, Kim JH, Khang SK et al (2008) Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients. Neurosurg Rev 31(1):35-43
17. Colli BO, Al-Mefty O(2001) Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 10(3):E1
18. Crockard HA, Steel T, Plowman N et al (2001) A multidisciplinary team approach to skull base chordomas. J Neurosurg 95 (2):175-183
19. Dahlin DC, MacCarty CS (1952) Chordoma: a study of fifty-nine cases. Cancer 5:1170-1178
20. Dalpra L, Malgara R, Miozzo M et al (1999) First cytogenetic study of a recurrent familial chordoma of the clivus. Int J Cancer 81:24-30
21. Debus J, Schulz-Ertner D, Schad L et al (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591-596
22. Deniz ML, Kiliç T, Almaata I et al (2002) Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 51(3):753-760
23. Dhall G, Traverso M, Finlay JL et al (2010) The role of chemotherapy in pediatric clival chordomas. J Neurooncol 103 (3):657-662
24. Erdem E, Angtuaco EC, Van Hemert R et al (2003) Comprehensive review of intracranial chordoma. Radiographics 23(4):995-1009
25. Eriksson B, Gunterberg B, Kindblom LG (1981) Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand 52(1):49-58
26. Fagundes MA, Hug EB, Liebsch NJ et al (1995) Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse. Int J Radiat Oncol Biol Phys 33(3):579-584
27. Forsyth PA, Cascino TL, Shaw EG et al (1993) Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 78(5):741-747
28. Gay E, Sekhar LN, Rubinstein E et al (1995) Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36(5):887-896
29. Gottschalk D, Fehn M, Patt S et al (2001) Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol 158(5):1571-1578
30. Guiu S, Guiu B, Feutray S et al (2009) Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report. Neurosurgery 65(3):E629-30
31. Haeckel C, Krueger S, Kuester D et al (2000) Expression of cathepsin K in chordoma. Hum Pathol 31(7):834-840
32. Heffelfinger MJ, Dahlin DC, MacCarty CS et al (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32:410-420
33. Higinbotham NL, Phillips RF, Farr HW et al (1967) Chordoma. Thirty-five-year study at memorial hospital. Cancer 20(11):1841-1850
34. Holton JL, Steel T, Luxsuwong Met al (2000) Skull base chordoma: correlation of tumor doubling time with age, mitosis and Ki67 proliferation index. Neuropathol Appl Neurobiol 26:497-503
35. Hu B, McPhaul L, Cornford M et al (1999) Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors. Am J Clin Pathol 112 (2):189-193
36. Hug EB, Fitzek MM, Liebsch NJ et al (1995) Locally challenging osteo and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using threedimensional treatment planning. Int J Radiat Oncol Biol Phys 31:467-476
37. Hug EB, Slater JD (2000) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 11:627-638
38. Ji Z, Long H, Hu Yet al (2010) Expression of MDR1, HIF-1alpha and MRP1 in sacral chordoma and chordoma cell line CM-319. J Exp Clin Cancer Res 29(1):158
39. Kamrin RP, Potanos JN, Pool JL et al (1964) An evaluation of the diagnosis and treatment of chordoma. J Neurol Neurosurg Psychiatry 27:157-165
40. Keisch ME, Garcia DM, Shibuya RB et al (1991) Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75(3):374-377
41. Kilgore S, Prayson RA (2002) Apoptotic and proliferative markers in chordomas: a study of 26 tumors. Ann Diagn Pathol 6(4):222-228
42. Kondziolka D, Lunsford LD, Flickinger JC (1991) The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery 29(1):38-46
43. Korten A, Berg H, Spincemaille GH et al (1998) Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry 65:88-92
44. Lanzino G, Dumont AS, Lopes MB et al (2001) Skull base chordomas: overview of disease, management options, and outcome. Neurosurg Focus 10(3):E12
45. Matsuno A, Sasaki T, Nagashima T et al (1997) Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas. Hum Pathol 28(6):714-719
46. Menezes AH, Sato Y (1995) Primary tumors of the spine in children-natural history and management. 1990. PediatrNeurosurg 23(2):101-113
47. Meyer JE, Oot RF, Lindfors KK (1986) CT appearance of clival chordomas. J Comput Assist Tomogr 10(1):34-38
48. Meyers SP, Hirsch WL Jr, Curtin HD et al (1992) Chordomas of the skull base: MR features. Am J Neuroradiol 13(6):1627-1636
49. Miozzo M, Dalprà L, Riva P et al (2000) A tumor suppressor locus in familial and sporadic chordoma maps to 1p36. Int J Cancer 87(1):68-72
50. Mori K, Chano T, Kushima R et al (2002) Expression of Ecadherin in chordomas: diagnostic marker and possible role of tumor cell affinity. Virchows Arch 440(2):123-127
51. Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlendher Onkol 175(Suppl 2):57-63
52. Muthukumar N, Kondziolka D, Lunsford LD et al (1998) Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 41:387-392
53. Naka T, Boltze C, Samii A et al (2003) Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer 98(9):1934-1941
54. Naka T, Fukuda T, Chuman H et al (1996) Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special referente to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum Pathol 27(4):381-388
55. Naka T, Iwamoto Y, Shinohara N et al (1997) Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression. Mod Pathol 10 (6):545-551
56. Naka T, Oda Y, Iwamoto Y et al (2001) Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gammacatenin, and neural cell adhesion molecule (NCAM) in chordoma. J Clin Pathol 54(12):945-950
57. Nishigaya K, Kaneko M, Ohashi Yet al (1998) Intradural retroclival chordoma without bone involvement: no tumor regrowth 5 years after operation. Case report. J Neurosurg 88(4):764-768
58. Noel G, Feuvret L, Calugaru Vet al (2005) Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44:700-708
59. O'Connell JX, Renard LG, Liebsch NJ et al (1994) Base of skull chordoma: a correlative study and clinical features of 62 cases. Cancer 74:2261-2267
60. O'Hara BJ, Paetau A, Miettinen M (1998) Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29(2):119-126
61. Orzan F, Terreni MR, Longoni M et al (2007) Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas. Oncol Rep 18(1):249-252
62. Paavolainen P, Teppo L (1967) Chordoma in Finland. Acta Orthop Scand 47:46-51
63. Pallini R, Maira G, Pierconti F et al (2003) Chordoma of the skull base: predictors of tumor recurrence. J Neurosurg 98(4):812-822
64. Pamir MN, Kiliç T, Türe U et al (2004) Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution. Acta Neurochir (Wien) 146(4):343-354
65. Park SA, Kim HS (2008) F-18 FDG PET/CT evaluation of sacrococcygeal chordoma. Clin Nucl Med 33(12):906-908
66. Pearlman AW, Friedman M (1970) Radical radiation therapy of chordoma. Am J Roentgenol Radium Ther Nucl Med 108:333-341
67. Presneau N, Shalaby A, Idowu B et al (2009) Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway. Br J Cancer 100(9):1406-1414
68. Raffel C, Wright DC, Gutin PH et al (1985) Cranial chordoma: clinical presentation and results of operative and radiation therapy in twenty-six patients. Neurosurgery 17:703-710
69. Rich TA, Schiller A, Suit HD et al (1985) Clinical and pathologic review of 48 cases of chordoma. Cancer 56:182-187
70. Riva P, Crosti F, Orzan F et al (2003) Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer 107(3):493-497
71. Roberti F, Sekhar LN, Jones RV et al (2007) Intradural cranial chordoma: a rare presentation of an uncommon tumor. Surgical experience and review of the literature. J Neurosurg 106(2):270-274
72. Rosenberg AE, Nielsen GP, Keel SB et al (1999) Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 23:1370-1378
73. Russel DS, Rubinstein LJ (1989) Pathology of tumors of the nervous system. Edward Arnold, London
74. Samii A, Gerganov VM, Herold C et al (2007) Chordomas of the skull base: surgical management and outcome. J Neurosurg 107 (2):319-324
75. Scheil S, Brüderlein S, Liehr T et al (2001) Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32(3):203-211
76. Schwab J, Antonescu C, Boland P et al (2009) Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. Anticancer Res 29(6):1867-1871
77. Sekhar LN, Pranatartiharan R, Chanda A et al (2001) Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus 10(3):E2
78. Sen C, Triana A (2001) Cranial chordomas: results of radical excision. Neurosurg Focus 10(3):E3
79. Sen C, Triana AI, Berglind N et al (2010) Clival chordomas: clinical management, results, and complications in 71 patients. J Neurosurg 113(5):1059-1071
80. Shalaby A, Presneau N, Ye H et al (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 223(3):336-346
81. Singhal N, Kotasek D, Parnis FX (2009) Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs 20 (10):953-955
82. Sommer J, Itani DM, Homlar KC et al (2010) Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220(5):608-617
83. Stacchiotti S, Marrari A, Tamborini E et al (2009) Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 20 (11):1886-1894
84. Stippler M, Gardner PA, Snyderman CH et al (2009) Endoscopic endonasal approach for clival chordomas. Neurosurgery 64 (2):268-278
85. Stüer C, Schramm J, Schaller C (2006) Skull base chordomas: management and results. Neurol Med Chir (Tokyo) 46(3):118-125
86. Suit HD, Goitein M, Munzenrider J et al (1982) Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg 56:377-385
87. Tai PT, Craighead P, Bagdon F (1995) Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques. Cancer 75(3):749-756
88. Tzortzidis F, Elahi F, Wright D et al (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59(2):230-237
89. Volpe NJ, Liebsch NJ, Munzenrider JE et al (1993) Neuroophthalmologic findings in chordoma and chondrosarcoma of the skull base. Am J Ophthalmol 115:97-104
90. Walker WP, Landas SK, Bromley CM et al (1991) Immunohistochemical distinction of classic and chondroid chordomas. Mod Pathol 4(5):661-666
91. Warnick RE, Raisanen J, Kaczmar T Jr et al (1991) Intradural chordoma of the tentorium cerebelli. Case report. J Neurosurg 74 (3):508-511
92. Watkins L, Khudados ES, Kaleoglu M et al (1993) Skull base chordoma: a review of 38 patients, 1958-88. Br J Neurosurg 7:241-248